Insufficient scRNA-seq data for expression of ASB1 at single-cell level.
Insufficient scRNA-seq data for expression of ASB1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4277.79 | 2642 / 2642 | 100% | 32.82 | 705 / 705 |
esophagus | 100% | 2944.90 | 1445 / 1445 | 100% | 9.76 | 183 / 183 |
prostate | 100% | 3082.47 | 245 / 245 | 100% | 10.81 | 500 / 502 |
intestine | 100% | 3329.77 | 966 / 966 | 99% | 10.84 | 524 / 527 |
lung | 100% | 2415.16 | 576 / 578 | 99% | 11.34 | 1149 / 1155 |
thymus | 100% | 2337.84 | 652 / 653 | 99% | 13.94 | 599 / 605 |
skin | 100% | 2745.29 | 1807 / 1809 | 99% | 15.94 | 465 / 472 |
stomach | 100% | 2384.53 | 359 / 359 | 98% | 9.80 | 281 / 286 |
breast | 100% | 2125.76 | 459 / 459 | 98% | 10.56 | 1098 / 1118 |
uterus | 100% | 4011.92 | 170 / 170 | 98% | 11.46 | 449 / 459 |
bladder | 100% | 3097.95 | 21 / 21 | 97% | 9.11 | 488 / 504 |
kidney | 100% | 2084.04 | 89 / 89 | 97% | 10.18 | 870 / 901 |
pancreas | 97% | 1223.13 | 318 / 328 | 99% | 12.74 | 177 / 178 |
ovary | 100% | 3116.23 | 180 / 180 | 96% | 8.30 | 412 / 430 |
adrenal gland | 100% | 1732.20 | 258 / 258 | 93% | 18.15 | 214 / 230 |
liver | 96% | 1233.68 | 218 / 226 | 82% | 6.38 | 332 / 406 |
adipose | 100% | 2128.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3609.00 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.81 | 29 / 29 |
muscle | 100% | 3669.39 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2739.82 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 11.35 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.52 | 1 / 1 |
heart | 98% | 3429.18 | 840 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 13.49 | 78 / 80 |
peripheral blood | 85% | 1507.12 | 792 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030539 | Biological process | male genitalia development |
GO_0001818 | Biological process | negative regulation of cytokine production |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0005829 | Cellular component | cytosol |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ASB1 |
Protein name | Ankyrin repeat and SOCS box containing 1 Ankyrin repeat and SOCS box protein 1 (ASB-1) |
Synonyms | KIAA1146 |
Description | FUNCTION: Probable substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins . Mediates Notch-induced ubiquitination and degradation of TCF3/E2A and JAK2 . May play a role in testis development (By similarity). . |
Accessions | ENST00000438264.5 B9A047 ENST00000409297.1 Q9Y576 F8WBM8 ENST00000264607.9 |